Algo version: 0.98b
Innovator IBD 50 is listed at the NYSE Exchange
Innovator IBD 50 [FFTY]
NYSE Sector: Financial Services Industry:Asset Management

Is Innovator IBD 50 stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Innovator IBD 50 pays dividends. Last time was Tuesday 2nd of January 2024 where the investors holding the stock on Thursday 28th of December 2023 were paid $0.15529 per share. Over the last 5 times between 2017 and 2023, Innovator IBD 50 has paid $0.91342973 with an average of $0.18 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Innovator IBD 50 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was $33.22, you would have made a loss of $-8.89 per share or -26.76%

Yes, the average daily trading liquidity for Innovator IBD 50 is $143 682 thousand. You should therefore be able to get in and out of your positions relatively fast.

Innovator IBD 50 has N/A of the business financed by loans. This puts the company at N/A risk in periods of high inflation where borrowing costs usually go up. With a N/A cash flow to debt ratio of 0, the company's ability to pay off the debt is N/A. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Innovator IBD 50 to be low [0 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.